Difference between revisions of "Pathology for medical students"

Jump to navigation Jump to search
Line 61: Line 61:
*[[Immunohistochemical stains]].
*[[Immunohistochemical stains]].
**[[Cancers of unknown primary]].
**[[Cancers of unknown primary]].
*Targeted therapies.
*Targeted therapies/molecular testing:
**Receptors in breast cancer.
**Receptors in breast cancer (ER, PR, HER2).
**Lung cancer biomarkers ([[Lung_carcinoma_with_EGFR_mutation|EGFR]], [[Lung carcinoma with ALK rearrangement|ALK]], PD-L1, [[ROS1-rearranged non-small cell lung carcinoma|ROS1]]).
**BRAF testing in malignant melanoma.
**[[Microsatellite instability in colorectal cancer|MSI testing]] in colorectal cancer.


==See also==
==See also==
48,453

edits

Navigation menu